| 2005 |
CKIε phosphorylates PER2, recruiting the ubiquitin E3 ligase adapter β-TrCP to a specific phosphodegron site, leading to PER2 ubiquitination and 26S proteasome-mediated degradation; CKIε inhibition slows PER2 degradation and lengthens circadian period in Rat-1 cells. |
Cell-based PER2 degradation assay, dominant-negative β-TrCP overexpression, proteasome inhibitors, CKIε inhibition, circadian period measurement in synchronized cells |
Molecular and cellular biology |
High |
15767683
|
| 2007 |
Phosphorylation of PER2 at S662 by CKIδ stabilizes PER2 and increases Per2 transcription; the FASPS S662G mutation causes PER2 hypophosphorylation at this site and advanced sleep phase; CKIδ dosage modulates the S662 phenotype, demonstrating CKIδ regulates period through PER2 in vivo. |
Transgenic mice carrying human FASPS PER2 S662G mutation, in vitro CKI phosphorylation assay, behavioral circadian analysis, CKIδ dosage manipulation |
Cell |
High |
17218255
|
| 2008 |
β-TrCP2 (as well as β-TrCP1) directly targets PER2 for degradation via a specific binding site (m2) on PER2; siRNA-mediated knockdown of β-TrCP1 and/or β-TrCP2 attenuates circadian oscillations in NIH3T3 cells. |
In vitro ubiquitin ligase assay, Luciferase-PER2 fusion stability assay, siRNA knockdown, real-time circadian reporter assay |
Journal of biochemistry |
High |
18782782
|
| 2006 |
Protein phosphatase 1 (PP1) dephosphorylates CKI-phosphorylated PER2, stabilizing it against ubiquitin-proteasome degradation; PER2 co-immunoprecipitates with PP1c in HEK-293 cells, mouse liver, and mouse brain; dominant-negative PP1c or PP1 inhibitors accelerate PER2 degradation and shorten PER2 half-life. |
Co-immunoprecipitation, Xenopus egg extract degradation assay, dominant-negative PP1c overexpression, PP1 inhibitor treatment, pulse-chase half-life measurement |
The Biochemical journal |
High |
16813562
|
| 2018 |
CK1δ/ε (including the CK1δ2 splice variant) serves as both the priming kinase and the downstream kinase for PER2; priming phosphorylation by CK1δ/ε initiates the phosphoswitch that stabilizes PER2 and lengthens circadian period; the CK1 C-terminal tail modulates period sensitivity to cellular signaling. |
Comprehensive biochemical and biophysical analysis of mPER2 priming phosphorylation in cells, mathematical phosphoswitch modeling, splice-variant comparison |
Proceedings of the National Academy of Sciences of the United States of America |
High |
29784789
|
| 2020 |
Phosphorylation of PER2 at Ser478 by CK1 creates a β-TrCP phosphodegron; PER2-S478A knock-in mice show longer circadian period, accumulation of PER2 protein in nucleus and cytoplasm of liver, increased nuclear PER1/CRY1/CRY2, and perturbed three-phase decay and temperature compensation of circadian period in fibroblasts. |
PER2-S478A knock-in mouse generation, behavioral circadian analysis, western blot, PER2::LUC bioluminescence in mouse embryonic fibroblasts |
Proceedings of the National Academy of Sciences of the United States of America |
High |
32354999
|
| 2020 |
A conserved anion binding site in CK1 controls activation loop conformation and determines which sites on PER2 (stabilizing vs. destabilizing) are preferentially phosphorylated; period-altering CK1 mutations from humans to Drosophila differentially modulate this activation loop switch to elicit predictable changes in PER2 stability. |
Integrated experimental and computational studies, mutagenesis of CK1 anion binding site, measurement of PER2 phosphorylation and stability |
eLife |
High |
32043967
|
| 2002 |
PER2 activates transcription of BMAL1; CRY1, CRY2, and PER2 together upregulate BMAL1 expression while BMAL1-CLOCK heterodimers repress it, forming an interlocked feedback loop in the mammalian circadian clock. |
Promoter-reporter luciferase assay, genomic structure characterization of mBmal1 |
Biochemical and biophysical research communications |
Medium |
11798163
|
| 2008 |
PER2 physically interacts with BMAL1 and CLOCK (but not CRY1/CRY2 with CLOCK); CRY proteins interact with BMAL1 at different domains than PER2; together PER2 and CRY proteins inhibit BMAL1-CLOCK transcriptional activation. |
Mammalian two-hybrid system, co-immunoprecipitation |
BMC molecular biology |
Medium |
18430226
|
| 2012 |
PML (promyelocytic leukemia protein) physically interacts with PER2 and promotes PER2 nuclear localization in SCN neurons; loss of PML shifts PER2 to a predominantly perinuclear/cytoplasmic distribution and disrupts clock gene rhythms; SIRT1 deacetylates PML at K487 to regulate PML control of PER2 nuclear localization. |
Co-immunoprecipitation, immunofluorescence localization, Pml-/- mouse analysis, SIRT1 deacetylation assay |
The EMBO journal |
High |
22274616
|
| 2022 |
CRY proteins are required for PER2 nuclear localization in SCN neurons; in the absence of CRY, PER2 is predominantly cytoplasmic and more mobile (measured by FRAP); virally expressed CRY1 or CRY2 relocalized PER2 to the nucleus and initiated SCN circadian rhythms; the C-terminal tail of CRY1 is necessary for PER2 nuclear relocalization. |
Confocal imaging of PER2::Venus reporter mice, viral vector expression of CRY variants, FRAP, translational switching to control CRY1 abundance |
Proceedings of the National Academy of Sciences of the United States of America |
High |
35046033
|
| 2017 |
PER2 interacts with HIF-1α via co-immunoprecipitation and facilitates recruitment of HIF-1α to the hypoxia-response element (HRE) of the VEGF promoter; this requires that HIF-1α N803 is unhydroxylated; PER2 enhances HIF-1 transcriptional activity without changing HIF-1α protein or mRNA levels. |
Co-immunoprecipitation, chromatin immunoprecipitation/HRE binding assay, N803A point mutant of HIF-1α, deferoxamine treatment |
The FEBS journal |
Medium |
28963769
|
| 2017 |
SIK3 promotes phosphorylation-dependent destabilization of PER2 protein; SIK3 knockdown increases PER2 protein levels while SIK3 overexpression decreases them; Sik3-deficient mice show elevated PER2 in fibroblasts and liver and lengthened circadian period. |
Sik3 knockout and knockdown in cells, western blot for PER2 protein levels, bioluminescence rhythm recording, liver fractionation |
eLife |
Medium |
29227248
|
| 2016 |
SIRT1 and PER2 form a reciprocal negative regulation loop: SIRT1 deficiency leads to enhanced H4K16 acetylation at the Per2 promoter causing Per2 overexpression; in turn, PER2 suppresses Sirt1 transcription by binding to the Sirt1 promoter at the Clock/Bmal1 site. |
Sirt1-deficient mouse model, ChIP assay for H4K16 acetylation at Per2 promoter, chromatin binding of PER2 at Sirt1 promoter, human hepatocyte validation |
Scientific reports |
Medium |
27346580
|
| 2019 |
SIRT6 interacts with and deacetylates PER2, preventing its proteasomal degradation; loss of Sirt6 disrupts circadian phase. |
Co-immunoprecipitation, deacetylation assay, Sirt6-knockout cells, circadian phase analysis |
Biochemical and biophysical research communications |
Medium |
30782483
|
| 2015 |
Clock-Bmal1 recruits the Ddb1-Cullin-4 ubiquitin ligase to Per1 and Per2 gene loci; rhythmic H2B monoubiquitination at Per genes depends on Bmal1, Ddb1, and Cullin-4a; this chromatin mark facilitates subsequent recruitment of the Per repressor complex to Clock-Bmal1 on DNA. |
ChIP for H2B monoubiquitination, depletion of Ddb1-Cullin-4a, circadian reporter assay, Co-IP of Per complex with Clock-Bmal1 |
Nature structural & molecular biology |
High |
26323038
|
| 2021 |
PER2 acts as a co-factor of CREB to facilitate assembly of the CREB/CRTC1/CBP transactivation complex on the CRE element of the Per1 gene regulatory region in response to light or forskolin; absence of PER2 abolishes CBP-CREB interaction, reduces histone H3 acetylation at the Per1 gene, and decreases RNA Pol II recruitment. |
In vitro and in vivo CREB/CRTC1/CBP interaction assays, ChIP for H3 acetylation and RNA Pol II, Per2-/- mouse light-stimulation experiments |
Scientific reports |
Medium |
34741086
|
| 2010 |
The PAS-B domain of mouse PER2 binds Fe(III) heme with 1:1 stoichiometry using His454 as an axial ligand; heme binding is pH-sensitive and shows faster dissociation kinetics than myoglobin, distinct from the PAS-A domain properties. |
Spectroscopic characterization (UV-Vis, CD), diethylpyrocarbonate treatment, H454A point mutant, heme dissociation kinetics |
Biochimica et biophysica acta |
Medium |
20887817
|
| 2004 |
Per2(Brdm1) mutant mice (with PAS domain deletion) show reduced expression of glutamate transporter Eaat1 in astrocytes, leading to decreased glutamate uptake, elevated extracellular glutamate, and increased alcohol consumption; acamprosate normalizes glutamate levels and alcohol intake in these mice. |
Per2 mutant mouse analysis, glutamate transporter expression and glutamate uptake assays, acamprosate pharmacological rescue, alcohol consumption measurement |
Nature medicine |
High |
15608650
|
| 2007 |
PER2 physically interacts with ERα (estrogen receptor-alpha); PER2 binding enhances ERα degradation, while Per2 suppression stabilizes ERα; PER2 overexpression in breast cancer cells causes growth inhibition, loss of clonogenic ability, and apoptosis; Per2 itself is estrogen-inducible suggesting a feedback loop. |
Co-immunoprecipitation, Per2 overexpression/knockdown, ERα stability (cycloheximide chase), colony formation and apoptosis assays |
Oncogene |
Medium |
17599055
|
| 2014 |
KSRP promotes decay of Per2 mRNA through direct RNA-protein interaction with the AU-rich element in the Per2 3' UTR; KSRP ablation increases Per2 expression and delays circadian phase of clock genes in liver, leading to reduced lipogenic gene expression. |
RNA-protein interaction assay, heterologous mRNA reporter with Per2 3' UTR, Ksrp-/- mice, primary hepatocyte culture, qRT-PCR |
Journal of lipid research |
Medium |
25514904
|
| 2023 |
PER2 binds to HSP90 through its PAS1 domain, reducing the interaction of HSP90 with IKKα/β; this promotes IKKα/β ubiquitination and inhibits IKK/NF-κB pathway activity, thereby suppressing PD-L1 expression in oral squamous cell carcinoma. |
Co-immunoprecipitation, GST pull-down, CHX chase assay, PAS1 domain deletion mutant, IKK ubiquitination assay, in vivo xenograft model |
Journal for immunotherapy of cancer |
Medium |
37914384
|
| 2021 |
Per1 and Per2 are required for activation of Igf2 (an autocrine promoter of myoblast differentiation); Per1/Per2 depletion suppresses RNA Pol II recruitment, reduces dynamic histone modifications at the Igf2 promoter and enhancer, and disrupts promoter-enhancer interaction, thereby impairing myoblast differentiation and muscle regeneration. |
Per1/Per2 siRNA depletion in myoblasts, ChIP for histone modifications and RNA Pol II, chromatin conformation capture, in vivo muscle regeneration after cardiotoxin injury |
The Journal of cell biology |
High |
34009269
|
| 2013 |
TNF-α inhibits Per2 transcription in rheumatoid synovial cells through D-box binding proteins DBP, HLF, TEF (activators) and E4BP4 (repressor); mutation of D-box 1 and D-box 2 motifs in the Per2 promoter abolished TNF-α-mediated transcriptional inhibition. |
Site-directed mutagenesis of Per2 promoter D-box motifs, luciferase reporter assay, qRT-PCR in primary synovial cells |
Scandinavian journal of rheumatology |
Medium |
23496259
|
| 2023 |
A minimal upstream open reading frame (uORF) in the 5' UTR of Per2 mediates temperature-dependent translational upregulation of PER2 protein without affecting Per2 transcription; PI3K lies upstream of this uORF-mediated translation; genetic ablation of the Per2 uORF impairs entrainment of cells to physiological body temperature cycles and delays wound healing in vivo. |
Genetic uORF ablation (knock-in mice), ribosome profiling, PI3K inhibition, cell entrainment to temperature cycles, wound healing assay |
Cell reports |
High |
36882059
|
| 2013 |
Egr1 binds directly to two Egr1-binding sites (EBS) in the Per2 promoter (positions -180 to -100) and mediates lithium-induced Per2 transcription; lithium activates the ERK1/2/Elk1 pathway to induce Egr1, which then drives Per2 expression; Egr1-/- mice show attenuated Per2 induction by lithium in frontal cortex. |
Serial promoter deletion reporter assays, EBS point mutation, EMSA, ChIP, Egr1 siRNA and Egr1-/- mouse |
Biochimica et biophysica acta |
High |
23816566
|
| 2014 |
Sevoflurane anesthesia reduces CLOCK binding to the E'-box in the Per2 promoter and decreases histone H4 acetylation at the proximal Per2 promoter region, suppressing Per2 expression in the SCN; this occurs independently of NAD+ levels in the SCN. |
ChIP with anti-acetylated histone H4 and anti-CLOCK antibodies, LC-MS for SCN NAD+ levels, in vitro SCN explant culture with Per2-dLuc reporter |
PloS one |
Medium |
24498074
|
| 2012 |
PER2 regulates AKT activity; cells with downregulated PER2 show prolonged high-level AKT T308 phosphorylation after growth factor stimulation or DNA damage; PER2 knockdown also delays DNA damage-induced Chk2 activation and overrides DNA damage-induced apoptosis and cell cycle arrest. |
PER2 siRNA knockdown, western blot for p-AKT T308 and p-Chk2, DNA damage assays, apoptosis and cell cycle analysis |
Biochemistry and cell biology |
Medium |
22905719
|
| 2010 |
Per2 deficiency enhances Ucp2 gene expression in the liver; absence of Per2 causes elevated Clock expression which drives Ucp2 upregulation via a Clock-controlled PPARα signal transduction pathway, leading to decreased intracellular ATP and increased susceptibility to CCl4-induced hepatotoxicity. |
Per2-null mice, qRT-PCR and protein analysis of Ucp2/Clock/PPARα, ATP measurement, histological analysis of liver injury |
The American journal of pathology |
Medium |
19056852
|
| 2019 |
PER2 periodically suppresses PCNA transcription by displacing the CLOCK-BMAL1 heterodimer from the PCNA promoter in a CRY1/2-dependent manner, thereby impeding oxaliplatin-induced DNA adduct repair in oral squamous cell carcinoma cells. |
Chromatin immunoprecipitation (pulldown) of CLOCK-BMAL1 from PCNA promoter, PER2 overexpression/knockdown, CRY1/2-dependent co-expression experiments, DNA adduct repair assays |
Advanced science |
Medium |
31728273
|
| 2021 |
PER2-mediated ameloblast differentiation operates through the PPARγ/AKT1/β-catenin signaling axis; Per2 knockdown decreases PPARγ expression and AKT1 phosphorylation and alters β-catenin localization; overexpression of PPARγ partially rescues Per2 knockdown phenotypes. |
Per2 knockdown by RNAi in ameloblast-lineage cells (ALC), overexpression of PPARγ as rescue, western blot for pathway components, in vivo circadian disruption mouse model with PPARγ agonist rescue |
International journal of oral science |
Medium |
34011974
|
| 2010 |
Endogenous dopamine regulates the daily rhythm of PER2 expression in the dorsal striatum through daily activation of D2 (but not D1) dopamine receptors; depletion of striatal dopamine (6-OHDA or α-methyl-para-tyrosine) or D2 receptor blockade blunts the PER2 rhythm; timed D2 receptor activation restores and entrains PER2 rhythm in dopamine-depleted striatum. |
6-OHDA and AMPT dopamine depletion, receptor-specific pharmacology (raclopride D2 blockade, D1/D2 agonists), immunohistochemistry for PER2 in rat brain regions |
The Journal of neuroscience |
Medium |
20962226
|
| 2008 |
Estrogen directly affects the circadian clock in the uterus: 17β-estradiol (E2) applied to explanted uterus cultures shortens the period of PER2::LUC expression; this effect is attenuated by raloxifene (estrogen receptor antagonist), indicating estrogen acts via estrogen receptors to modulate PER2 rhythms in the uterus but not the SCN. |
PER2::LUC tissue explant culture from ovariectomized knockin mice, estrogen/raloxifene treatment, bioluminescence recording |
American journal of physiology. Endocrinology and metabolism |
Medium |
18728223
|
| 2006 |
Per2 mutant mice lack food-anticipatory activity under restricted feeding conditions, while Per1 mutants and wild-type mice show normal food anticipation; peripheral phase shifts of clock-gene expression in response to timed food restriction are comparable across all genotypes, placing PER2 specifically in a central food-entrainable oscillator pathway but not peripheral feeding synchronization. |
Per2 and Per1 mutant mouse behavioral analysis (rest-activity, body temperature rhythms), clock-gene expression in SCN and peripheral tissues under restricted feeding |
Current biology |
High |
17055980
|
| 2017 |
Per2 mutation in mice (PAS domain deletion) is associated with increased cyclooxygenase-1 (but not COX-2) protein levels in aorta, decreased NO production, and altered prostaglandin production, leading to impaired endothelium-dependent relaxation; endothelial dysfunction is not associated with hypertension or dyslipidemia. |
Organ chamber studies with aortic rings, Western blot for COX-1/COX-2/eNOS, pharmacological dissection with indomethacin, Per2 mutant mouse model |
Circulation |
Medium |
17404161
|
| 2015 |
Per2 mutation in MEFs increases resistance to ROS-induced cytotoxicity; this is paralleled by altered Bcl-2 expression; elevated survival and altered NADH/NAD+ ratio in mutant cells is reversed by reintroduction of wild-type Per2; clock-synchronized cells display time-dependent sensitivity to paraquat. |
Per2 mutant MEFs, ROS (paraquat) treatment, cell viability assay, Bcl-2 expression, NADH/NAD+ measurement, wild-type Per2 rescue |
Frontiers in neurology |
Medium |
25628599
|
| 2023 |
PER2 enhances HIF-1α transcriptional activity to induce cell cycle genes Ccnb2, Cdc20, and Espl1 in pituitary cells; PER2 upregulation in jet-lagged mice accelerates pituitary adenoma growth, while Per2 loss protects against estrogen-induced pituitary adenoma; SR8278 (which decreases PER2 expression) has anti-tumor effects. |
RNA-seq, in vivo jet-lag and estrogen-induced pituitary adenoma models, PER2 overexpression/KO, HIF-1α ChIP, luciferase reporter for HIF-1α target genes |
Theranostics |
Medium |
37215573
|